
Healthy snacking habits on the rise in Saudi Arabia
Freeze-drying has emerged as a popular way to process fruits in a move away from traditional drying with heat, which can cause nutrients such as vitamins, antioxidants and fiber to be depleted. Freeze-drying causes less degradation and ensures more goodness is retained.
'When I first tried freeze-dried strawberries, I loved them,' Riyadh resident Abdullah Saud told Arab News. 'Because I have diabetes I am not allowed to consume a lot of sugar or fruits, but the strawberries are great. They are not sugary, for my taste.'
• Public health physician Dr. Zahra'a Al-Ahmed, who specializes in nutrition, warned that while freeze-dried fruit retained structure and flavor, it could still be high in calories.
• The Saudi Food and Drug Authority's Healthy Food Promotion Initiative is reducing unhealthy additives in food products to improve nutritional labeling.
• Dates are an option for a classic Saudi snack, widely popular due to their cultural and religious significance.
However, public health physician Dr Zahra'a Al-Ahmed, who specializes in nutrition, warned that while freeze-dried fruit retained structure and flavor, it could still be high in calories.
Speaking to Arab News about snacking habits and the shift to healthier options, she said: 'Similar to many other nations, Saudi Arabia has major issues with diabetes, obesity and heart disease. These non-communicable diseases are frequently associated with poor eating habits, such as consuming too many processed snacks that are heavy in sodium, sugar and bad fats.'
The trend towards healthier choices indicated the community was increasingly aware of these risks and was making the effort to reduce such problems, she said: 'Low-calorie, sugar-free, gluten-free, high-fiber and protein-rich products are among the clean label options that consumers are actively looking for.'
Al-Ahmed said consumers' snacking habits in the Kingdom were changing thanks to various programs that 'encourage improved eating habits towards mindful eating.'
One such scheme is the Saudi Food and Drug Authority's Healthy Food Promotion Initiative, which aims to reduce unhealthy additives in food products and improve nutritional labeling, encouraging consumers to make informed decisions.
Al-Ahmed explained that people's consumption habits were influenced by multiple factors, including socioeconomic status, education level and social as well as emotional triggers.
Despite improving attitudes towards diets in the Kingdom, unhealthy snacks are still popular, especially among college students and young adults. More programs targeting these groups were needed, she added.
Dates are another option for a classic Saudi snack, widely popular due to their cultural and religious significance. They have always been valued for their natural sweetness and nutritional benefits, and new, healthier versions are being found in cafes and on supermarket shelves.
From chocolate-covered Ajwa dates to those stuffed with almonds, pistachios or peanut butter, the much-loved fruit is finding favor in new forms.
'I love date bars — healthy and tasty — and I make a lot for myself and for my family instead of buying regular chocolate at the supermarket,' said Munirah Al-Fahad, from Riyadh. 'It gives me the same taste but with less sugar and (fewer) fats.'
She revealed: 'The base for this snack is dates, followed by a layer of peanut butter, then topped by chocolate mixed with nuts. I leave it after that in the refrigerator to cool for two hours, sometimes less.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Argaam
10 hours ago
- Argaam
Avalon Pharma signs EUR 3M contract to market GLP1 products
Middle East Pharmaceutical Industries Co. (Avalon Pharma) signed a contract worth EUR 3 million with Adalvo Limited, a global pharmaceutical company headquartered in Malta, to secure the rights for the registration and marketing their GLP 1 products for weight loss and obesity. In a statement to Tadawul, the company said that the contract is valid for seven years, adding that the agreement allows Avalon Pharma to register, market and distribute the product under its Trademark in select countries of Middle East and North Africa, with exclusive rights for Saudi Arabia. The agreement is forecast to generate SAR 294 million over the duration of the contract, once regulatory approvals are received, and sales commence. Prior to going to market, the company will ensure receiving full approvals from the Saudi Arabian Food and Drug Authority (SFDA) as well as the respective authorities in each country in which it will market and distribute the product, the statement added. The deal includes provisions for expanding to other GLP products and potential for localized manufacturing. Avalon Pharma also expected that the performance will reflect positively in a gradual manner as sales accelerate post-launch, noting that no related parties are included in the deal. Any material developments, including expected launch date, related to this agreement will be communicated in due course, the statement indicated.


Argaam
a day ago
- Argaam
Saudi German Health OKs resignation of nominations and remuneration committee Chairman
Middle East Healthcare Co.'s (Saudi German Health) board of directors approved the resignation of Mohammed Moemena, an independent board member and Chairman of the nominations and remuneration committee. The resignation, submitted on July 2, was due to differences in opinion, perspectives, and a lack of alignment in vision and aspirations, the company said in a statement to Tadawul. The resignation became effective as of Aug. 3. In addition, Saudi German Health appointed Muhammad bin Siddiq as Chairman of the nominations and remuneration committee as of Aug. 3 to complete the current committee term, which is set to end on Sep. 16, 2026. Muhammad bin Siddiq holds a bachelor's degree in business administration from King Abdulaziz University and has over 40 years of experience in management across both listed and private companies. He previously served as a board member, Chairman of the nominations and remuneration committee, and a member of the audit committee at Zahr Al Burtuqal Co. (Orange Bed & Bath). Moreover, the board appointed Ghazi Ahmed Hasanain as an independent member to fill the vacant seat on the board as of today, Aug. 4. He will serve for the remainder of the current board term ending Sept. 16, 2026. Ghazi has more than 40 years of experience in management, engineering, higher education, consulting, and the healthcare sector. He holds a PhD in civil engineering from the University of Missouri-Rolla in the US and held academic and leadership roles at several institutions, including King Abdulaziz University, King Fahd University of Petroleum and Minerals, and King Abdullah University of Science and Technology (KAUST). The board's approval of the appointments is provisional and will be presented at the upcoming general assembly meeting for confirmation, the statement said.


Arab News
3 days ago
- Arab News
Estithmar Holding reports record results for H1 2025
Revealing an exceptional performance across all key financial metrics, Estithmar Holding Q.P.S.C. has announced its financial results for the six-month period ending June 30, 2025. The company reported revenue of 3.07 billion Qatari riyals ($844 million), an 87 percent year-on-year increase. The gross profit soared by 134 percent to 1.05 billion Qatari riyals, while EBITDA rose 97 percent to 732 million Qatari riyals compared to H1 2024. The net profit reached 465 million Qatari riyals, up 97 percent year-on-year, while earnings per share doubled, reaching 0.13 Qatari riyals. While Estithmar Holding continues its upward trajectory in its financial and operational indicators across all its financial disclosures, this remarkable leap in results for H1 2025 is mainly attributed to increased revenue through its international expansions across its four sectors in Saudi Arabia, Iraq, Algeria, Libya, Maldives, Jordan, and Kazakhstan. The company's enhanced operational performance also underpinned an EBITDA of 732 million Qatari riyals, an increase of 97 percent, driven by disciplined financial and operational policies, which improved the profit margin. 'Our exceptional first half performance demonstrates the strength of our strategy. By focusing on value creation, sector leadership and disciplined capital allocation, we have delivered greater operational efficiency, robust revenue growth and margin expansion,' said Juan Leon, group CEO of Estithmar Holding. He added: 'Sustained and balanced growth across our four clusters remains central to our investment strategy. We continue to drive innovation and adopt advanced operational technologies. With a distinctive blend of capabilities and expertise, Estithmar Holding is well placed to deliver exceptional stakeholder value and extend our footprint globally.' Currently, Estithmar Holding's operations span seven countries in addition to Qatar. The health care sector has expanded to Algeria, developing the Algerian Qatari German Hospital, Iraq through the management of Al-Imam Al-Hassan Al-Mujtaba Hospital and Al-Nasiriyah Teaching Hospital in Karbala and Di-Qar governorates, and to Libya, managing Misrata Heart and Vascular Center. The real estate development and tourism division features major projects such as Rixos Baghdad Hotel and Residences in Iraq and the Rosewood Resort in the Maldives, both progressing at an accelerated pace. The services division has expanded its operations across Saudi Arabia, Iraq, Maldives, Libya, Jordan, and Kazakhstan, sustaining revenue growth through operational diversification and scale. Specialized contracting activities have also expanded in Saudi Arabia, having been awarded major projects such as Red Sea Airport, five hotels in Shura Island, Sindalah Yacht Club and others, besides projects in the Maldives, and Iraq. Record share performance Estithmar Holding's share showed robust and sustained upward momentum during H1 2025, climbing 77 percent. This indicates a transition from steady accumulation to a sharp upward trend, driven by increased investor confidence, ongoing profit growth, and the company's expansion activities. The company's share performance reflects its sound management and operational policies focused on enhancing investor value. This aligns with the company's long-standing commitments expressed in previous statements, alongside the launch of diversified projects and expansion initiatives.